EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy

Takahiro Hayashi, Naoko Yano, Kengo Kora, Atsushi Yokoyama, Kanako Maizuru, Taisei Kayaki, Kinuko Nishikawa, Mitsujiro Osawa, Akira Niwa, Toshiki Takenouchi, Atsushi Hijikata, Tsuyoshi Shirai und 5 weitere

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddad008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Takahiro Hayashi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: Vesicular Transport Proteins, Brain Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome, AMED, Core Center for iPS Cell Research of Research Center Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive factor (NSF), a homohexameric ATPase, disassembles the complex, allowing individual SNARE proteins to be recycled. Recently, the association between pathogenic NSF variants and developmental and epileptic encephalopathy (DEE) was reported; however, the molecular pathomechanism of NSF-related DEE remains unclear. Here, three patients with de novo heterozygous NSF variants were presented, of which two were associated with DEE and one with a very mild phenotype. One of the DEE patients also had hypocalcemia from parathyroid hormone deficiency and neuromuscular junction impairment. Using PC12 cells, a neurosecretion model, we show that NSF with DEE-associated variants impaired the recycling of vesicular membrane proteins and vesicle enlargement in response to exocytotic stimulation. In addition, DEE-associated variants caused neurodegenerative change and defective autophagy through overactivation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. Treatment with rapamycin, an mTOR inhibitor or overexpression of wild-type NSF ameliorated these phenotypes. Furthermore, neurons differentiated from patient-derived induced pluripotent stem cells showed neurite degeneration, which was also alleviated by rapamycin treatment or gene correction using genome editing. Protein structure analysis of NSF revealed that DEE-associated variants might disrupt the transmission of the conformational change of NSF monomers and consequently halt the rotation of ATP hydrolysis, indicating a dominant negative mechanism. In conclusion, this study elucidates the pathomechanism underlying NSF-related DEE and identifies a potential therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vesicular Transport ProteinsBrain DiseasesAnimalsRatsSNARE ProteinsMembrane FusionN-Ethylmaleimide-Sensitive ProteinsNeurotransmitter AgentsMammalsTOR Serine-Threonine Kinases

Substanzen

Vesicular Transport ProteinsSNARE ProteinsN-Ethylmaleimide-Sensitive ProteinsNeurotransmitter AgentsmTOR protein, ratTOR Serine-Threonine KinasesNsf protein, rat

Autor:innen und Institutionen

  • Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
  • Thyas Co. Ltd, Kyoto 606-8501, Japan.
  • Department of Clinical Application, Center for iPS Cell Research and Application (CiRA) Kyoto University, Kyoto 606-8507, Japan.
  • Department of Pediatrics, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan.
  • Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan.
  • School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.

ORCID-Profile: Takeshi Yoshida

Förderung

  • Wellcome
  • AMED
  • Core Center for iPS Cell Research of Research Center Network
  • JSPS KAKENHI

Zitieren

APA

Hayashi, T., Yano, N., Kora, K., Yokoyama, A., Maizuru, K., Kayaki, T., Nishikawa, K., Osawa, M., Niwa, A., Takenouchi, T., Hijikata, A., Shirai, T., Suzuki, H., Kosaki, K., Saito, M. K., Takita, J., & Yoshida, T. (2023). Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad008

Vancouver

Hayashi T, Yano N, Kora K, Yokoyama A, Maizuru K, Kayaki T, et al. Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad008

BibTeX
@article{Hayashi2023,
  author = {Hayashi, Takahiro and Yano, Naoko and Kora, Kengo and Yokoyama, Atsushi and Maizuru, Kanako and Kayaki, Taisei and Nishikawa, Kinuko and Osawa, Mitsujiro and Niwa, Akira and Takenouchi, Toshiki and Hijikata, Atsushi and Shirai, Tsuyoshi and Suzuki, Hisato and Kosaki, Kenjiro and Saito, Megumu K and Takita, Junko and Yoshida, Takeshi},
  title = {Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddad008}
}
Kostenlos starten →